← Back to headlines
Relmada Therapeutics Among Best Growth Stocks Under $30
Relmada Therapeutics (RLMD) is listed as one of the top 10 growth stocks priced under $30, suggesting it is a favorable investment opportunity.
19 Jun, 07:01 — 19 Jun, 07:01
Sources
Showing 1 of 1 sources
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
20m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
28m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
49m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
55m ago